BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18777001)

  • 21. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
    Faber L; Meissner A; Ziemssen P; Seggewiss H
    Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
    Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-drug treatment for hypertrophic obstructive cardiomyopathy in children].
    Zhang X; Li YF; Xie B; Chen JY; Qian MY
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):381-5. PubMed ID: 21624293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.
    Nakamura K; Toba T; Otake H; Kakizaki S; Fujimoto D; Takahashi Y; Fukuyama Y; Kawamori H; Tanaka H; Takaya T; Iwasaki M; Kozuki A; Kawai H; Hayashi T; Shite J; Hirata KI
    Heart Vessels; 2022 Nov; 37(11):1937-1946. PubMed ID: 35641828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.
    Faber L; Seggewiss H; Gietzen FH; Kuhn H; Boekstegers P; Neuhaus L; Seipel L; Horstkotte D
    Z Kardiol; 2005 Aug; 94(8):516-23. PubMed ID: 16049653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy ].
    Welge D; Seggewiss H; Fassbender D; Schmidt HK; Horstkotte D; Faber L
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1949-54. PubMed ID: 18798130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Singh K; Qutub M; Carson K; Hibbert B; Glover C
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.
    Sathyamurthy I; Nayak R; Oomman A; Subramanyan K; Kalarical MS; Mao R; Ramachandran P
    Indian Heart J; 2014; 66(1):57-63. PubMed ID: 24581097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Batzner A; Pfeiffer B; Neugebauer A; Aicha D; Blank C; Seggewiss H
    J Am Coll Cardiol; 2018 Dec; 72(24):3087-3094. PubMed ID: 30545446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
    J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
    Noble S; Sigwart U
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
    Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ
    Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
    Sivakumar K; Jain G
    Pediatr Cardiol; 2024 Mar; 45(3):648-659. PubMed ID: 36995405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
    Faber L; Seggewiss H; Gleichmann U
    Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
    Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
    Fitzgerald P; Kusumoto F
    J Interv Card Electrophysiol; 2018 Aug; 52(3):403-408. PubMed ID: 30097789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.